Metastatic Uveal Melanoma:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Metastatic Uveal Melanoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Metastatic Uveal Melanoma 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Metastatic Uveal Melanoma Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Metastatic Uveal Melanoma 25
Jun 01, 2013: AstraZeneca’s New Therapy Selumetinib Improves Progression-Free Survival And Shrink Tumors In Metastatic Uveal Melanoma, Researchers Report 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Novartis AG 26
Clinical Trial Overview of Novartis AG 26
AstraZeneca PLC 27
Clinical Trial Overview of AstraZeneca PLC 27
GlaxoSmithKline plc 28
Clinical Trial Overview of GlaxoSmithKline plc 28
Spectrum Pharmaceuticals, Inc. 29
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 29
Clinical Trial Overview of Top Institutes / Government 30
National Cancer Institute 30
Clinical Trial Overview of National Cancer Institute 30
The Clatterbridge Cancer Centre NHS Foundation Trust 31
Clinical Trial Overview of The Clatterbridge Cancer Centre NHS Foundation Trust 31
The University of Texas M. D. Anderson Cancer Center 32
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 32
Alberta Health Services 33
Clinical Trial Overview of Alberta Health Services 33
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital 34
Clinical Trial Overview of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital 34
Memorial Sloan Kettering Cancer Center 35
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 35
Ludwig-Maximilians-Universitat Munich 36
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 36
University Hospital, Essen 37
Clinical Trial Overview of University Hospital, Essen 37
Barnes Retina Institute 38
Clinical Trial Overview of Barnes Retina Institute 38
University of California, Los Angeles 39
Clinical Trial Overview of University of California, Los Angeles 39
Five Key Clinical Profiles 40
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95


【レポート販売概要】

■ タイトル:Metastatic Uveal Melanoma:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2078CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。